DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection

Infection and Immunity

Volumn 68, Issue 9, 2000, Pages 4986-4991

  Sepulveda, P ^a   Hontebeyrie, M ^a   Liegeard, P ^a   Mascilli, A ^a   Norris, K A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT REGULATORY PROTEIN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL IMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; STRUCTURAL GENE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

ANIMALS; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; COMPLEMENT INACTIVATOR PROTEINS; CYTOKINES; IMMUNIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0033855423     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.9.4986-4991.2000     Document Type: Article

References (23)

1. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi
2. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice
3. DNA vaccines
4. Cell-mediated immunity in experimental Trypanosoma cruzi
5. Protective antibodies in Trypanosoma cruzi infections: Detection, functional activity and possible mechanisms of trypomastigote killing in vivo and in vitro
6. Protective effects of specific antibodies in Trypanosoma cruzi infections
7. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies
8. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi
9. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
10. Endogenous IL-10 and INF-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi
11. Trypanosoma cruzi: Protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response
12. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the complement regulatory protein, decay accelerating factor
13. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies
14. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance
15. Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease
16. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi
17. Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein
18. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi
19. The role of T cells in Trypanosoma cruzi infections
20. Chagas disease etiology: Autoimmunity or parasite persistence?
21. 'Autoimmune rejection' of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue
22. Vaccination with trypomastigore surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection
23. Control of Chagas disease